🇺🇸 FDA
Pipeline program

AS01 adjuvant (0.5 mL intramuscular)

AS01-YF-01

Phase 2 mab active

Quick answer

AS01 adjuvant (0.5 mL intramuscular) for Immune System Responses and Trained Immunity After AS01 Administration is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Immune System Responses and Trained Immunity After AS01 Administration
Phase
Phase 2
Modality
mab
Status
active

Clinical trials